UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach

Journal of medicinal chemistry, 1988-11, Vol.31 (11), p.2103-2107

1988

Volltextzugriff (PDF)

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine

Journal of medicinal chemistry, 1980-12, Vol.23 (12), p.1442-1445

1980

Volltextzugriff (PDF)

Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle

The Journal of pharmacology and experimental therapeutics, 1983-05, Vol.225 (2), p.291

1983

Volltextzugriff (PDF)

Calcium channels in smooth muscle. Properties and regulation

Annals of the New York Academy of Sciences, 1989, Vol.560 (1), p.215-229

1989

Volltextzugriff (PDF)

Chemical and pharmacological approaches to the definition and quantitation of calcium channels

Cold Spring Harbor Symposia on Quantitative Biology, 1983-01, Vol.48 Pt 1, p.279-285

1983

Volltextzugriff (PDF)

Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines

Journal of medicinal chemistry, 1971-06, Vol.14 (6), p.499-501

1971

Volltextzugriff (PDF)

2,4-diamino-6-substituted-5- (4-Carbethoxyphenylazo) Pyrimidines as Irreversible Inhibitors of Folic Acid Reductase

Journal of pharmaceutical sciences, 1966-04, Vol.55 (4), p.453-454

1966

Volltextzugriff (PDF)

6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites

Journal of medicinal chemistry, 1966-11, Vol.9 (6), p.874

1966

Volltextzugriff (PDF)

2-Halogenoethylamines as Potential Folic Acid Antagonists I. Synthesis and Biological Activity of Ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)- propyl]-p-aminobenzoate

Journal of pharmaceutical sciences, 1965-05, Vol.54 (5), p.795-797

1965

Volltextzugriff (PDF)

5-Substituted Pyrimidines. II. The Synthesis of 2-Amino-4-hydroxy-6-methyl-5-(2-hydroxy-3-amino)propylpyrimidines

Journal of medicinal chemistry, 1967-03, Vol.10 (2), p.285-285

1967

Volltextzugriff (PDF)

Potential folic acid antagonists. III. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines

Journal of medicinal chemistry, 1968-05, Vol.11 (3), p.583-588

1968

Volltextzugriff (PDF)

Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines

Journal of medicinal chemistry, 1965-11, Vol.8 (6), p.745-749

1965

Volltextzugriff (PDF)

6-Substituted 2,4-Diamino-5-(4-carbethoxyphenylazo)pyrimidines as Potential Precursors of Tetrahydropteridine Antimetabolites1

Journal of medicinal chemistry, 1966-11, Vol.9 (6), p.874-876

1966

Volltextzugriff (PDF)

Potential Folic Acid Antagonists. I. The Antitumor and Folic Acid Reductase Inhibitory Properties of 6-Substituted 2,4-Diamino-5-arylazopyrimidines1

Journal of medicinal chemistry, 1965-11, Vol.8 (6), p.745-749

1965

Volltextzugriff (PDF)

Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines

Journal of medicinal chemistry, 1968-05, Vol.11 (3), p.583

1968

Volltextzugriff (PDF)

Calcium Channels in Smooth Muscle

Annals of the New York Academy of Sciences, 1989-06, Vol.560 (1), p.215-229

1989

Volltextzugriff (PDF)

ChemInform Abstract: CRYSTAL STRUCTURES OF CALCIUM CHANNEL ANTAGONISTS: 2,6‐DIMETHYL‐3,5‐DICARBOMETHOXY‐4‐(2‐NITRO‐, 3‐CYANO‐, 4‐(DIMETHYLAMINO)‐, AND 2,3,4,5,6‐PENTAFLUOROPHENYL)‐1,4‐DIHYDROPYRIDINE

Chemischer Informationsdienst, 1981-04, Vol.12 (16)

1981

Volltextzugriff (PDF)

Studies on the Surface Treatment of Aluminium and Zinc

Transactions of the Institute of Metal Finishing, 1960-01, Vol.37 (1), p.56-64

1960

Volltextzugriff (PDF)

6-Substituted 2,4-Diamino-5-(4-carbethoxyphenylazo)pyrimidines as Potential Precursors of Tetrahydropteridine Antimetabolites 1

Journal of medicinal chemistry, 1966-11, Vol.9 (6), p.874-876

1966

Volltextzugriff (PDF)

Potential Folic Acid Antagonists. I. The Antitumor and Folic Acid Reductase Inhibitory Properties of 6-Substituted 2,4-Diamino-5-arylazopyrimidines 1

Journal of medicinal chemistry, 1965-11, Vol.8 (6), p.745-749

1965

Volltextzugriff (PDF)

ChemInform Abstract: POTENTIELLE FOLSAEURE‐ANTAGONISTEN 4. MITT. SYNTH. UND DIHYDROFOLAT‐REDUKTASE‐INHIBITORWIRKUNG VON 2,4,6‐TRIAMINO‐5‐ARYLAZO‐PYRIMIDINEN

Chemischer informationsdienst. Organische Chemie, 1971-10, Vol.2 (40)

1971

Volltextzugriff (PDF)

Effects of oxidative and thermal stresses on stress granule formation in human induced pluripotent stem cells

PloS one, 2017-07, Vol.12 (7), p.e0182059-e0182059

2017

Volltextzugriff (PDF)

Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.314-323

2016

Volltextzugriff (PDF)

Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress

Vascular pharmacology, 2018-10, Vol.109, p.56-71

2018

Volltextzugriff (PDF)

Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights

Vascular health and risk management, 2024-06, Vol.20, p.255-288

2024

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(202)

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(126)
Animals
(121)
Pharmacology & Pharmacy
(98)
Biological And Medical Sciences
(61)
Male
(57)
Rats
(56)
Medical Sciences
(49)
In Vitro Techniques
(43)
Pharmacology. Drug Treatments
(37)
Physiology
(35)
Guinea Pigs
(32)
Calcium - Metabolism
(27)
Muscle Contraction - Drug Effects
(27)
Mice
(25)
Neurosciences
(25)
Neurosciences & Neurology
(24)
Muscle, Smooth - Drug Effects
(22)
Calcium Channel Blockers - Pharmacology
(20)
Cardiovascular System
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine

Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle

Calcium channels in smooth muscle. Properties and regulation

Chemical and pharmacological approaches to the definition and quantitation of calcium channels

Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines

2,4-diamino-6-substituted-5- (4-Carbethoxyphenylazo) Pyrimidines as Irreversible Inhibitors of Folic Acid Reductase

6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites

2-Halogenoethylamines as Potential Folic Acid Antagonists I. Synthesis and Biological Activity of Ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)- propyl]-p-aminobenzoate

5-Substituted Pyrimidines. II. The Synthesis of 2-Amino-4-hydroxy-6-methyl-5-(2-hydroxy-3-amino)propylpyrimidines

Potential folic acid antagonists. III. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines

Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines

6-Substituted 2,4-Diamino-5-(4-carbethoxyphenylazo)pyrimidines as Potential Precursors of Tetrahydropteridine Antimetabolites1

Potential Folic Acid Antagonists. I. The Antitumor and Folic Acid Reductase Inhibitory Properties of 6-Substituted 2,4-Diamino-5-arylazopyrimidines1

Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines

Calcium Channels in Smooth Muscle

ChemInform Abstract: CRYSTAL STRUCTURES OF CALCIUM CHANNEL ANTAGONISTS: 2,6‐DIMETHYL‐3,5‐DICARBOMETHOXY‐4‐(2‐NITRO‐, 3‐CYANO‐, 4‐(DIMETHYLAMINO)‐, AND 2,3,4,5,6‐PENTAFLUOROPHENYL)‐1,4‐DIHYDROPYRIDINE

Studies on the Surface Treatment of Aluminium and Zinc

6-Substituted 2,4-Diamino-5-(4-carbethoxyphenylazo)pyrimidines as Potential Precursors of Tetrahydropteridine Antimetabolites 1

Potential Folic Acid Antagonists. I. The Antitumor and Folic Acid Reductase Inhibitory Properties of 6-Substituted 2,4-Diamino-5-arylazopyrimidines 1

ChemInform Abstract: POTENTIELLE FOLSAEURE‐ANTAGONISTEN 4. MITT. SYNTH. UND DIHYDROFOLAT‐REDUKTASE‐INHIBITORWIRKUNG VON 2,4,6‐TRIAMINO‐5‐ARYLAZO‐PYRIMIDINEN

Effects of oxidative and thermal stresses on stress granule formation in human induced pluripotent stem cells

Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin

Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress

Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights

Suchergebnisse filtern